Join
Live feed
·
INSIDERFilingvia Quantisnow
Cytosorbents Corporation logo

Chief Medical Officer Deliargyris Efthymios was granted 70,000 shares, increasing direct ownership by 17% to 473,025 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
CTSO· Cytosorbents Corporation
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CTSO (Cytosorbents Corporation) and more on Quantisnow.